References
- Heffron JJ. Malignant hyperthermia: biochemical aspects of the acute episode. Br J Anaesth 1988: 60(3): 274–8
- Rosenberg H. Malignant hyperthermia. Hasp Pratt 1985: 139(Mar 15): 139–52
- Denborough MA, Lovell RR. Anaesthetic deaths in a family. (Letter) Lancet 1960: 2(Jul 2): 45
- Tomarken JL, Britt BA. Malignant hyperthermia. Ann Emerg Med 1987: 16(11): 1253–65
- Sesaler DI. Malignant hyperthermia. J Pediatr 1986: 109(1): 9–14
- Rosenberg H. Clinical presentation of malignant hyperthermia. Br J Anaesth 1988: 60(3): 268–73
- Braude BM, Press P, Moyes DG, et al. Unexpected hyperthermia manifesting during outpatient anesthesia. Anesthesiology 1986: 64(5): 647–50
- Flewellen EH, Nelson TE. Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia. (Letter) Anesthesiology 1984: 61(4): 477
- Gronert GA, Mott J, Lee J. Aetiology of malignant hyperthermia. Br J Anaesth 1988: 60(3): 253–67
- Brownell AK. Malignant hyperthermia: relationship to other diseases. Br J Anaesth 1988: 60(3): 303–8
- Harriman DG. Malignant hyperthermia myopathy: a critical review. Br J Anaesth 1988: 60(3): 309–16
- Guzé BH, Baxter LR Jr. Neuroleptic malignant syndrome. N Engl J Med 1985: 313(3): 163–6
- Ording H. Diagnosis of susceptibility to malignant hyperthermia in man. Br J Anaesth 1988: 60(3): 287–302
- Olgin J, Argov Z, Rosenberg H, et al. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. Anesthesiology 1988: 68(4): 507–13